Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selumetinib with HAART in AIDS-associated Kaposi's sarcoma
ISRCTN24921472Phase 2Terminated
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Mar 2012
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of selumetinib in Kaposi sarcoma (KS), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Objective response rate. Started Mar 2012; status: terminated.
02
Drugs
selumetinib
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on ISRCTN24921472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN24921472.